Bruker (BRKRP) Invested Capital (2009 - 2026)

Bruker (BRKRP) has 18 years of Invested Capital data on file, last reported at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 32.33% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 32.33% YoY), and the FY2025 full-year result was $2.5 billion, up 38.17% from the prior year.
• Invested Capital for Q1 2026 stood at $2.5 billion, down from $2.5 billion in the prior quarter.
• Across five years, Invested Capital topped out at $2.5 billion in Q4 2025 and bottomed at $965.0 million in Q3 2022.
• The 5-year median for Invested Capital is $1.5 billion (2023), against an average of $1.6 billion.
• The widest annual swing landed in 2022, when Invested Capital plunged 53.13%; it then soared 39.7% in 2023.
• A 5-year view of Invested Capital shows it stood at $1.1 billion in 2022, then surged by 33.69% to $1.5 billion in 2023, then rose by 18.89% to $1.8 billion in 2024, then surged by 38.17% to $2.5 billion in 2025, then dropped by 0.59% to $2.5 billion in 2026.
• The last three Invested Capital figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.

Peer Comparison